Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-17

Clinical Trial Update: Add-on Dextromethorphan in Bipolar Disorders [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating add-on dextromethorphan for bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextromethorphan (dextromethorphan)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED